Pages that link to "Q36969009"
Jump to navigation
Jump to search
The following pages link to Proteins, drug targets and the mechanisms they control: the simple truth about complex networks (Q36969009):
Displaying 50 items.
- Function, regulation and pathological roles of the Gab/DOS docking proteins (Q21245511) (← links)
- Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cells (Q24311542) (← links)
- Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein (Q24322676) (← links)
- Systems genetics for drug target discovery (Q27012769) (← links)
- Dynamic rendering of the heterogeneous cell response to anticancer treatments (Q27324055) (← links)
- Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs (Q28305100) (← links)
- Network-based identification of biomarkers coexpressed with multiple pathways (Q28397059) (← links)
- Search algorithms as a framework for the optimization of drug combinations (Q28474246) (← links)
- Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir (Q28477930) (← links)
- Quantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cells (Q28478299) (← links)
- Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways (Q28478650) (← links)
- Towards structural systems pharmacology to study complex diseases and personalized medicine (Q28538838) (← links)
- Synergistic and antagonistic drug combinations depend on network topology (Q28542101) (← links)
- Utilizing the molecular gateway: the path to personalized cancer management. (Q30371443) (← links)
- Models of signalling networks - what cell biologists can gain from them and give to them (Q30413382) (← links)
- Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis (Q30536784) (← links)
- Directed evolution generates a novel oncolytic virus for the treatment of colon cancer (Q33344440) (← links)
- Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets (Q33347888) (← links)
- A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scores (Q33355830) (← links)
- Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures (Q33416583) (← links)
- A formal model for analyzing drug combination effects and its application in TNF-alpha-induced NFkappaB pathway (Q33563358) (← links)
- Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity (Q33658626) (← links)
- CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma (Q33732597) (← links)
- Confidence from uncertainty--a multi-target drug screening method from robust control theory (Q33755473) (← links)
- Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society (Q33850616) (← links)
- Targeting oncogenic protein-protein interactions by diversity oriented synthesis and combinatorial chemistry approaches. (Q33915473) (← links)
- Network target for screening synergistic drug combinations with application to traditional Chinese medicine (Q33937467) (← links)
- Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. (Q34005286) (← links)
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? (Q34088265) (← links)
- Dissecting cancer through mathematics: from the cell to the animal model (Q34100311) (← links)
- Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis (Q34101667) (← links)
- Optimal homeostasis necessitates bistable control (Q34270962) (← links)
- Drug discovery: engineering drug combinations (Q34624616) (← links)
- Chemoinformatics in the New Era: From Molecular Dynamics to Systems Dynamics. (Q35947657) (← links)
- Signalling by protein phosphatases and drug development: a systems-centred view. (Q36012977) (← links)
- Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemia. (Q36018192) (← links)
- Diverse array-designed modes of combination therapies in Fangjiomics (Q36123974) (← links)
- Evidence of perturbations of the cytokine network in preterm labor (Q36372845) (← links)
- Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues (Q36444728) (← links)
- Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches. (Q36466007) (← links)
- Tunable ultrasensitivity: functional decoupling and biological insights (Q36548895) (← links)
- Accelerating cancer systems biology research through Semantic Web technology (Q36572429) (← links)
- A portrait of tissue phosphoprotein stability in the clinical tissue procurement process (Q36919993) (← links)
- The evolving role of nuclear molecular imaging in cancer. (Q37011086) (← links)
- High-throughput kinase profiling as a platform for drug discovery (Q37135359) (← links)
- Finding multiple target optimal intervention in disease-related molecular network. (Q37170511) (← links)
- Advanced systems biology methods in drug discovery and translational biomedicine (Q37220252) (← links)
- Physiologically relevant binding affinity quantification of monoclonal antibody PF-00547659 to mucosal addressin cell adhesion molecule for in vitro in vivo correlation (Q37572883) (← links)
- Antibody-based proteomics: analysis of signaling networks using reverse protein arrays (Q37622475) (← links)
- Systems approaches and algorithms for discovery of combinatorial therapies (Q37787998) (← links)